Aurealis Pharma

Aurealis Pharma is a biopharmaceutical company dedicated to developing breakthrough drugs for the treatment of cancer and chronic wounds. They focus on the research and development of gene and cell therapies, as well as the creation of new active molecules through computational modeling of naturally derived compounds. Their primary strategy is to conduct cutting-edge interdisciplinary R&D and apply it to innovative business models. They are actively seeking collaborations with pharmaceutical companies, academic research institutions, and preclinical CROs.